F.D.A. Clears New Cancer-Fighting Drug From Roche

.

F.D.A. Clears New Cancer-Fighting Drug From Roche

A new drug from the drug company Roche has been given the nod by the US Food and Drug Administration (FDA) to improve the treatment of patients suffering from a kind of cancer of the blood and bone marrow.

Roche is calling the new medicine Gazyva which is meant to fight chronic lymphocytic leukemia along with added treatment with chemotherapy. It is meant for those patients who have never before been treated for the same.

Gazyva provides relief in this cancer by destroying cancer cells and enabling the natural immune system of the body to fight against them.

The FDA gave its approval to Gazyva after proof that the drug along with chemotherapy was a better treatment to chemotherapy alone in slowing the progress of the cancer cells.

It was also seen that cancer patients who got treatment from Gazyva combined with chemotherapy had a higher survival rate with 23 months before death, relapse or spreading of the cancer cells.

Earlier treatments treated only with chemotherapy only got 11.1 months.

The new drug Gazyva will be sold by Roche s Genentech unit.


Latest News

Three crew members missing and one injured after train collision in Texas
Home Prices Gain in the U.S in April with Seven Cities Marking Record High
Although Revised First-Quarter G.D.P. Showed an Upward Move but Still Reflects a
A Story of Cooperation Turned Sour; Airbnb Sues San Francisco over New Rules
Researchers says dogs might help detect hypoglycemia in diabetes patients
Millions of Dressers and Chests Recalled by IKEA  Following Deaths and Injuries
Pepsi to Reintroduce Diet Coke with Aspartame
Volkswagen Agrees to Pay $14.7 Billion as Settlement in the U.S Related to Diese
Hawaii enrols all gun owners into FBI Database for monitoring
Ten people injured at California rally
IMF’s Christine Lagarde Says Impact of Brexit will Depend on What Move Policy Ma
Oil Prices Tumble with British Pound Facing a Fresh Fall